In a study aiming to determine if EGFR mediates the pathogenesis of hyperlipidemia/obesity-related cardiac diseases, EGFR inhibition significantly ameliorated myocardial fibrosis, apoptosis, and inflammation in two rat models of obesity (Li et al., 2016). The gene discussed is EGFR; the disease is hyperlipidemia.